HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Oral B Pro Most-Recommended Claim Backed By P&G's Global Dentist Surveys

This article was originally published in The Rose Sheet

Executive Summary

UK Advertising Standards Authority says it rejected a complaint challenging whether the claim “number one dentist recommended brand worldwide” that P&G made in a TV ad was misleading and could be substantiated. P&G Health & Beauty Care Ltd. business in England responds with explanation of surveys with dentists it commissions to determine the professionals' regards for Oral B manual and power brushes.

You may also be interested in...



Nothing Cosmetic About P&G Oral-B Enamel Repair Claims, UK Review Finds

UK's advertising regulator agrees that P&G's TV ads for Oral B Gum and Enamel Repair toothpaste were misleading.  P&G argued ad claims that the product could fix enamel and reverse damage were cosmetic, not medicinal, because they only suggested the product could protect gums and promote overall oral health.

P&G’s Oral B 100% Stain Removal Claim Passes Muster With ASA

Following a Colgate challenge, the ASA examines a P&G clinical study submitted in support of its claim that Oral B 3D White Luxe Perfection toothpaste “removes up to 100% of surface stains in 3 days.”

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121768

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel